Joachim F. Wernicke
Technik-/Wissenschafts-/F&E-Leiter bei REPROS THERAPEUTICS INC
Aktive Positionen von Joachim F. Wernicke
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
REPROS THERAPEUTICS INC | Technik-/Wissenschafts-/F&E-Leiter | 05.02.2013 | - |
Karriereverlauf von Joachim F. Wernicke
Ehemalige bekannte Positionen von Joachim F. Wernicke
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CYBERONICS, INC. | General Counsel | - | - |
MediGen Group LLC
MediGen Group LLC Investment ManagersFinance Founded in 2001 by Ronald Zimmerman, MediGen Group LLC is a venture capital firm located in Houston, Texas | Private Equity Investor | - | - |
Ausbildung von Joachim F. Wernicke
University of California, Los Angeles | Doctorate Degree |
University of California, Irvine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Doctorate Degree | 2 |
Private Equity Investor | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
MediGen Group LLC
MediGen Group LLC Investment ManagersFinance Founded in 2001 by Ronald Zimmerman, MediGen Group LLC is a venture capital firm located in Houston, Texas | Finance |
Repros Therapeutics, Inc.
Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
LivaNova USA, Inc.
LivaNova USA, Inc. Medical SpecialtiesHealth Technology LivaNova USA, Inc. engages in the design, development, sales, and marketing of implantable medical devices. It operates through providing neuromodulation therapy, vagus nerve stimulation therapy (VNS Therapy) for the treatment of refractory epilepsy, and treatment-resistant depression (TRD). The company was founded in 1987 and is headquartered in Granbury, TX. | Health Technology |
- Börse
- Insiders
- Joachim F. Wernicke
- Erfahrung